arsenic trioxide has been researched along with Experimental Neoplasms in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Bersimbaev, RI; Bhattacharya, R; Ellis, L; Hung, MC; Lee, MG; Lin, HK; Park, M; Peterson, CB; Sarbassov, DD; Sarbassova, DA; Song, MS; Wu, X; Ying, H | 1 |
| Hu, X; Li, X; Liu, T; Peng, Y; Tan, W; Wei, X; Zhang, X; Zhao, Z | 1 |
| Aster, JC; Avigan, D; Bhasin, MK; Cheloni, G; Chen, M; Clohessy, JG; Galinsky, I; Guarnerio, J; Lane, AA; Lee, JD; Lo-Coco, F; Longo, L; Mendez, L; Menon, AV; Monteleone, E; Mugoni, V; Pandolfi, PP; Panella, R; Pozdnyakova, O; Stone, RM; Stroopinsky, D; Zamora, JC | 1 |
| Fei, W; Guo, M; Li, F; Liu, Y; Wei, Y; Xiao, X; Zhang, R; Zhang, Y; Zheng, G; Zheng, H | 1 |
| Bu, Q; Cai, QQ; Gao, Y; Huang, HQ; Li, S; Liao, H; Zhou, Y | 1 |
| Du, Y; Lai, R; Liu, H; Zhang, D | 1 |
| Kakadiya, R; Lee, PC; Lee, TC; Su, TL | 1 |
| Beachy, PA; Gardner, D; Kim, J; Lee, JJ | 1 |
| Amano, S; Gao, Y; Gu, C; Koizumi, S; Namba, H; Tokuyama, T; Yokota, N | 1 |
| Ahn, WS; Bae, SM; Bang, HJ; Battogtokh, G; Kim, YW | 1 |
| Chen, J; Hu, W; Lanza, GM; Shen, B; Wang, K; Zhang, B; Zhang, L; Zhao, F | 1 |
| Alexandre, J; Annereau, M; Batteux, F; Chéreau, C; Dauphin, A; Goldwasser, F; Lemare, F; Mongaret, C; Nicco, C; Thomas-Schoemann, A; Weill, B | 1 |
| Brown, SL; Kim, JH; Kolozsvary, A; Lew, YS | 1 |
| Huang, SG; Jiang, S; Kong, BH; Yang, RF | 1 |
| Brouet, JC; Chopin, M; Dosquet, C; Fermand, JP; Janin, A; Labaume, S; Larghero, J; Marolleau, JP; Poupon, J; Rousselot, P | 1 |
| Goldberg, SN; Hines-Peralta, A; Liu, ZJ; Regan, M; Signoretti, S; Sukhatme, V | 1 |
| Björklund, NE; Nordberg, G; Pershagen, G | 1 |
| Hisanaga, A; Inamasu, T; Ishinishi, N | 1 |
| Liang, X; Lin, C; Xu, M | 1 |
19 other study(ies) available for arsenic trioxide and Experimental Neoplasms
| Article | Year |
|---|---|
A chirality-dependent action of vitamin C in suppressing Kirsten rat sarcoma mutant tumor growth by the oxidative combination: Rationale for cancer therapeutics.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Ascorbic Acid; Drug Synergism; HCT116 Cells; Humans; Isomerism; Mice, Nude; Mutation; Neoplasms, Experimental; Oxidative Stress; Proto-Oncogene Proteins p21(ras); Xenograft Model Antitumor Assays | 2020 |
Smart Human-Serum-Albumin-As
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Folate Receptor 2; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Nanoparticles; Neoplasms, Experimental; Serum Albumin, Human; Structure-Activity Relationship | 2017 |
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Disease Models, Animal; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neoplasms, Experimental; Tretinoin; Tumor Cells, Cultured; U937 Cells | 2019 |
pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
Topics: Absorption, Physicochemical; Acrylic Resins; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Coated Materials, Biocompatible; Delayed-Action Preparations; Drug Delivery Systems; Drug Synergism; Female; Humans; Hydrogen-Ion Concentration; Male; Nanocapsules; Nanopores; Neoplasms, Experimental; Oxides; Rats; Rats, Sprague-Dawley; Silicon Dioxide; Treatment Outcome | 2016 |
Effects of arsenic trioxide under different administration ways on T-cell lymphoma xenografts in nude mice: in vivo and in vitro experiments.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Flow Cytometry; Inhibitory Concentration 50; Lymphoma, T-Cell; Male; Mice; Mice, Nude; Microscopy, Electron; Microscopy, Fluorescence; Neoplasms, Experimental; Oxides; Time Factors; Tumor Burden | 2009 |
Thermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9.
Topics: Animals; Arsenic Trioxide; Arsenicals; Female; Ferrosoferric Oxide; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Hyaluronan Receptors; Hyperthermia, Induced; Matrix Metalloproteinase 9; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Oxides; Vascular Endothelial Growth Factor C; Xenograft Model Antitumor Assays | 2009 |
Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Carbamates; Cell Line, Tumor; Cell Proliferation; Cell Separation; Drug Resistance, Neoplasm; Drug Synergism; Flow Cytometry; Fluorescent Antibody Technique; Heterocyclic Compounds, 3-Ring; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mice; Mice, Nude; Neoplasms, Experimental; Oxides; Signal Transduction; Xenograft Model Antitumor Assays | 2010 |
Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector.
Topics: Animals; Arsenic Trioxide; Arsenicals; Arsenites; Cerebellar Neoplasms; Dose-Response Relationship, Drug; Hedgehog Proteins; Kruppel-Like Transcription Factors; Luciferases; Luminescent Proteins; Medulloblastoma; Mice; Mice, Knockout; Mice, Nude; Neoplasms, Experimental; NIH 3T3 Cells; Oxides; Protein Stability; Recombinant Fusion Proteins; Signal Transduction; Sodium Compounds; Transfection; Transplantation, Homologous; Tumor Suppressor Protein p53; Zinc Finger Protein Gli2 | 2010 |
Molecular targeting therapy against promyelocytic leukemia protein using arsenic acids in experimental intracranial medulloblastoma.
Topics: Animals; Antineoplastic Agents; Arsenates; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cerebellar Neoplasms; Cytarabine; Humans; Medulloblastoma; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplasms, Experimental; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Transcription Factors; Tumor Suppressor Proteins | 2012 |
Synergistic anti-tumor effects of combination of photodynamic therapy and arsenic compound in cervical cancer cells: in vivo and in vitro studies.
Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Mice; Neoplasm Proteins; Neoplasms, Experimental; Oxides; Photochemotherapy; Uterine Cervical Neoplasms | 2012 |
Near infrared imaging of EGFR of oral squamous cell carcinoma in mice administered arsenic trioxide.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Body Weight; Carbocyanines; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Epidermal Growth Factor; ErbB Receptors; Gene Expression; Injections, Intraperitoneal; Injections, Intravenous; Magnetic Resonance Imaging; Mice; Mice, Nude; Mouth Neoplasms; Neoplasms, Experimental; Oxides; Recombinant Fusion Proteins; Spectroscopy, Near-Infrared; Tumor Burden; Tumor Cells, Cultured | 2012 |
Arsenic trioxide exerts antitumor activity through regulatory T cell depletion mediated by oxidative stress in a murine model of colon cancer.
Topics: Animals; Arsenic Trioxide; Arsenicals; CD8-Positive T-Lymphocytes; Colonic Neoplasms; Enzyme Inhibitors; Female; Fluorescein; Fluoresceins; Humans; Immunotherapy, Adoptive; Lymphocyte Activation; Lymphocyte Depletion; Metalloporphyrins; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxidative Stress; Oxides; Reactive Nitrogen Species; Reactive Oxygen Species; Superoxide Dismutase; T-Lymphocytes, Regulatory | 2012 |
Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Combined Modality Therapy; Dose Fractionation, Radiation; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Oxides; Radiation-Sensitizing Agents; Tumor Necrosis Factor-alpha | 2002 |
[Primary study of arsenic trioxide inhibits abdomino-metastatic tumor formation of human ovarian carcinoma in nude mice and its mechanisms].
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Disease Models, Animal; Fas Ligand Protein; fas Receptor; Female; Humans; Membrane Glycoproteins; Mice; Mice, Nude; Monomeric GTP-Binding Proteins; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Ovarian Neoplasms; Oxides; Transcription Factors; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Arsenic trioxide is effective in the treatment of multiple myeloma in SCID mice.
Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Division; Humans; Immunoglobulin G; Melarsoprol; Mice; Mice, SCID; Multiple Myeloma; Neoplasm Transplantation; Neoplasms, Experimental; Oxides; Plasma Cells; Receptors, Interleukin-6; Survival Analysis; Tissue Distribution; Xenograft Model Antitumor Assays | 2004 |
Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Coagulation; Carcinoma, Renal Cell; Catheter Ablation; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Growth Inhibitors; Humans; Laser-Doppler Flowmetry; Mice; Mice, Nude; Neoplasms, Experimental; Oxides; Rabbits; Rats; Rats, Inbred F344; Regional Blood Flow; Sarcoma | 2006 |
Carcinomas of the respiratory tract in hamsters given arsenic trioxide and/or benzo[a]pyrene by the pulmonary route.
Topics: Animals; Arsenic; Arsenic Trioxide; Arsenicals; Benzo(a)pyrene; Benzopyrenes; Carcinogens; Charcoal; Cricetinae; Drug Synergism; Dust; Lung Neoplasms; Male; Mesocricetus; Neoplasms, Experimental; Oxides | 1984 |
Comparison of arsenic trioxide and calcium arsenate retention in the rat lung after intratracheal instillation.
Topics: Animals; Arsenates; Arsenic; Arsenic Trioxide; Arsenicals; Lung; Lung Neoplasms; Male; Neoplasms, Experimental; Oxides; Rats; Rats, Inbred Strains | 1982 |
[Experimental study on combination of Ad-p53 with CDDP or As(2)O(3) in human lung adenocarcinoma cell line GLC-82].
Topics: Adenocarcinoma; Adenoviridae; Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cisplatin; Combined Modality Therapy; Disease Models, Animal; Genetic Therapy; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Oxides; Transfection; Transplants; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2000 |